Cargando…

Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women

Meibomian gland dysfunction (MGD) is believed to be the leading cause of dry eye (DE) disease worldwide. The connection between aging and MGD has long been recognized. However, few studies have addressed the relationship between MGD and hormone replacement therapy (HRT) in perimenopausal women, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xiuming, Lin, Zhenyun, Liu, Yufang, Lin, Lin, Zhu, Binbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979784/
https://www.ncbi.nlm.nih.gov/pubmed/27495030
http://dx.doi.org/10.1097/MD.0000000000004268
_version_ 1782447374403108864
author Jin, Xiuming
Lin, Zhenyun
Liu, Yufang
Lin, Lin
Zhu, Binbin
author_facet Jin, Xiuming
Lin, Zhenyun
Liu, Yufang
Lin, Lin
Zhu, Binbin
author_sort Jin, Xiuming
collection PubMed
description Meibomian gland dysfunction (MGD) is believed to be the leading cause of dry eye (DE) disease worldwide. The connection between aging and MGD has long been recognized. However, few studies have addressed the relationship between MGD and hormone replacement therapy (HRT) in perimenopausal women, and not have examined the prevalence of MGD in perimenopausal women. The purpose of this study was to address and evaluate the possible relationship between MGD and HRT in perimenopausal women. The results suggest that perimenopausal women have a high prevalence of DE related to perimenopausal symptoms. The study also shows that perimenopausal women who use HRT can gain benefits for DE as well as for perimenopausal symptoms. Physicians caring for women who are experiencing DE related to perimenopausal symptoms should consider HRT.
format Online
Article
Text
id pubmed-4979784
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49797842016-08-18 Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women Jin, Xiuming Lin, Zhenyun Liu, Yufang Lin, Lin Zhu, Binbin Medicine (Baltimore) 7400 Meibomian gland dysfunction (MGD) is believed to be the leading cause of dry eye (DE) disease worldwide. The connection between aging and MGD has long been recognized. However, few studies have addressed the relationship between MGD and hormone replacement therapy (HRT) in perimenopausal women, and not have examined the prevalence of MGD in perimenopausal women. The purpose of this study was to address and evaluate the possible relationship between MGD and HRT in perimenopausal women. The results suggest that perimenopausal women have a high prevalence of DE related to perimenopausal symptoms. The study also shows that perimenopausal women who use HRT can gain benefits for DE as well as for perimenopausal symptoms. Physicians caring for women who are experiencing DE related to perimenopausal symptoms should consider HRT. Wolters Kluwer Health 2016-08-07 /pmc/articles/PMC4979784/ /pubmed/27495030 http://dx.doi.org/10.1097/MD.0000000000004268 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 7400
Jin, Xiuming
Lin, Zhenyun
Liu, Yufang
Lin, Lin
Zhu, Binbin
Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women
title Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women
title_full Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women
title_fullStr Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women
title_full_unstemmed Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women
title_short Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women
title_sort hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women
topic 7400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979784/
https://www.ncbi.nlm.nih.gov/pubmed/27495030
http://dx.doi.org/10.1097/MD.0000000000004268
work_keys_str_mv AT jinxiuming hormonereplacementtherapybenefitsmeibomianglanddysfunctioninperimenopausalwomen
AT linzhenyun hormonereplacementtherapybenefitsmeibomianglanddysfunctioninperimenopausalwomen
AT liuyufang hormonereplacementtherapybenefitsmeibomianglanddysfunctioninperimenopausalwomen
AT linlin hormonereplacementtherapybenefitsmeibomianglanddysfunctioninperimenopausalwomen
AT zhubinbin hormonereplacementtherapybenefitsmeibomianglanddysfunctioninperimenopausalwomen